« Back to Record
Citation APA

Dushyanthen, S., Kershaw, M. M., Trapani, J. J., Neeson, P. P., Salgado, R., McArthur, G. A., Balko, J. M., Beavis, P. P., Darcy, P. K., Loi, S., Teo, Z. L., Caramia, F., Savas, P., Mintoff, C. P., Virassamy, B., Henderson, M. M., Luen, S., & Mansour, M. (2017). Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. Nature communications, 8(1), 606. doi:10.1038/s41467-017-00728-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/260756

Dushyanthen, S., Kershaw, M. M., Trapani, J. J., Neeson, P. P., Salgado, R., McArthur, G. A., Balko, J. M., Beavis, P. P., Darcy, P. K., Loi, S., Teo, Z. L., Caramia, F., Savas, P., Mintoff, C. P., Virassamy, B., Henderson, M. M., Luen, S., & Mansour, M. (2017). Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. Nature communications, 8(1), 606. doi:10.1038/s41467-017-00728-9